Literature DB >> 12270683

An inducible mouse model of late onset Tay-Sachs disease.

Mylvaganam Jeyakumar1, David Smith, Elena Eliott-Smith, Mario Cortina-Borja, Gabriele Reinkensmeier, Terry D Butters, Thorsten Lemm, Konrad Sandhoff, V Hugh Perry, Raymond A Dwek, Frances M Platt.   

Abstract

Mouse models of the G(M2) gangliosidoses, Tay-Sachs and Sandhoff disease, are null for the hexosaminidase alpha and beta subunits respectively. The Sandhoff (Hexb-/-) mouse has severe neurological disease and mimics the human infantile onset variant. However, the Tay-Sachs (Hexa-/-) mouse model lacks an overt phenotype as mice can partially bypass the blocked catabolic pathway and escape disease. We have investigated whether a subset of Tay-Sachs mice develop late onset disease. We have found that approximately 65% of the mice develop one or more clinical signs of the disease within their natural life span (n = 52, P < 0.0001). However, 100% of female mice with repeat breeding histories developed late onset disease at an earlier age (n = 21, P < 0.0001) and displayed all clinical features. Repeat breeding of a large cohort of female Tay-Sachs mice confirmed that pregnancy induces late onset Tay-Sachs disease. Onset of symptoms correlated with reduced up-regulation of hexosaminidase B, a component of the bypass pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270683     DOI: 10.1006/nbdi.2002.0511

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  5 in total

Review 1.  The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Authors:  Debra S Regier; Richard L Proia; Alessandra D'Azzo; Cynthia J Tifft
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

Review 2.  Substrate reduction therapy in mouse models of the glycosphingolipidoses.

Authors:  Frances M Platt; Mylvaganam Jeyakumar; Ulrika Andersson; Tanya Heare; Raymond A Dwek; Terry D Butters
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

3.  Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

Authors:  Stephan D Gadola; Jonathan D Silk; Aruna Jeans; Petr A Illarionov; Mariolina Salio; Gurdyal S Besra; Raymond Dwek; Terry D Butters; Frances M Platt; Vincenzo Cerundolo
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

Review 4.  Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.

Authors:  Bernadette Breiden; Konrad Sandhoff
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

5.  Efficient and precise generation of Tay-Sachs disease model in rabbit by prime editing system.

Authors:  Yuqiang Qian; Ding Zhao; Tingting Sui; Mao Chen; Zhiquan Liu; Hongmei Liu; Tao Zhang; Siyu Chen; Liangxue Lai; Zhanjun Li
Journal:  Cell Discov       Date:  2021-07-06       Impact factor: 10.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.